134 related articles for article (PubMed ID: 11008204)
1. Bcl-2 expression is associated with improved prognosis in patients with distal colorectal adenocarcinomas.
Manne U; Weiss HL; Grizzle WE
Int J Cancer; 2000 Sep; 89(5):423-30. PubMed ID: 11008204
[TBL] [Abstract][Full Text] [Related]
2. Molecular staging of colorectal cancer in African-American and Caucasian patients using phenotypic expression of p53, Bcl-2, MUC-1 AND p27(kip-1).
Grizzle WE; Manne U; Weiss HL; Jhala N; Talley L
Int J Cancer; 2002 Feb; 97(4):403-9. PubMed ID: 11802199
[TBL] [Abstract][Full Text] [Related]
3. Nuclear accumulation of p53 in colorectal adenocarcinoma: prognostic importance differs with race and location of the tumor.
Manne U; Weiss HL; Myers RB; Danner OK; Moron C; Srivastava S; Grizzle WE
Cancer; 1998 Dec; 83(12):2456-67. PubMed ID: 9874449
[TBL] [Abstract][Full Text] [Related]
4. Recurrence and survival predictive value of phenotypic expression of Bcl-2 varies with tumor stage of colorectal adenocarcinoma.
Chatla C; Jhala NC; Katkoori VR; Alexander D; Meleth S; Grizzle WE; Manne U
Cancer Biomark; 2005; 1(4-5):241-50. PubMed ID: 17192048
[TBL] [Abstract][Full Text] [Related]
5. Racial differences in the prognostic usefulness of MUC1 and MUC2 in colorectal adenocarcinomas.
Manne U; Weiss HL; Grizzle WE
Clin Cancer Res; 2000 Oct; 6(10):4017-25. PubMed ID: 11051251
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of p27(kip-1) expression in colorectal adenocarcinomas is associated with tumor stage.
Manne U; Jhala NC; Jones J; Weiss HL; Chatla C; Meleth S; Suarez-Cuervo C; Grizzle WE
Clin Cancer Res; 2004 Mar; 10(5):1743-52. PubMed ID: 15014027
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the correlation between p53 and bcl-2 expression with staging and prognosis of the colorectal adenocarcinoma.
Lustosa SA; Logullo A; Artigiani R; Saad SS; Goldenberg A; Matos D
Acta Cir Bras; 2005; 20(5):353-7. PubMed ID: 16186958
[TBL] [Abstract][Full Text] [Related]
8. p53 Nuclear accumulation and Bcl-2 expression in contiguous adenomatous components of colorectal adenocarcinomas predict aggressive tumor behavior.
Shanmugam C; Katkoori VR; Jhala NC; Grizzle WE; Siegal GP; Manne U
J Histochem Cytochem; 2008 Mar; 56(3):305-12. PubMed ID: 18071066
[TBL] [Abstract][Full Text] [Related]
9. Combined role of tumor angiogenesis, bcl-2, and p53 expression in the prognosis of patients with colorectal carcinoma.
Giatromanolaki A; Stathopoulos GP; Tsiompanou E; Papadimitriou C; Georgoulias V; Gatter KC; Harris AL; Koukourakis MI
Cancer; 1999 Oct; 86(8):1421-30. PubMed ID: 10526268
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in resectable pancreatic cancer: p53 and bcl-2.
Bold RJ; Hess KR; Pearson AS; Grau AM; Sinicrope FA; Jennings M; McConkey DJ; Bucana CD; Cleary KR; Hallin PA; Chiao PJ; Abbruzzese JL; Evans DB
J Gastrointest Surg; 1999; 3(3):263-77. PubMed ID: 10481119
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical expression of bcl-2 in Dukes' stage B and C colorectal carcinoma patients: correlation with p53 and ki-67 in evaluating prognostic significance.
Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
Pol J Pathol; 2005; 56(4):179-85. PubMed ID: 16477877
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of Bcl-2 expression and p53 nuclear accumulation in colorectal adenocarcinoma.
Manne U; Myers RB; Moron C; Poczatek RB; Dillard S; Weiss H; Brown D; Srivastava S; Grizzle WE
Int J Cancer; 1997 Jun; 74(3):346-58. PubMed ID: 9221816
[TBL] [Abstract][Full Text] [Related]
13. The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction.
Ishida H; Irie K; Itoh T; Furukawa T; Tokunaga O
Cancer; 1997 Sep; 80(6):1034-45. PubMed ID: 9305703
[TBL] [Abstract][Full Text] [Related]
14. Prognostic evaluation of CD44 expression in correlation with bcl-2 and p53 in colorectal cancer.
Zavrides HN; Zizi-Sermpetzoglou A; Panousopoulos D; Athanasas G; Elemenoglou I; Peros G
Folia Histochem Cytobiol; 2005; 43(1):31-6. PubMed ID: 15871560
[TBL] [Abstract][Full Text] [Related]
15. Bcl-2 protein expression: association with p53 and prognosis in colorectal cancer.
Kaklamanis L; Savage A; Whitehouse R; Doussis-Anagnostopoulou I; Biddolph S; Tsiotos P; Mortensen N; Gatter KC; Harris AL
Br J Cancer; 1998 Jun; 77(11):1864-9. PubMed ID: 9667660
[TBL] [Abstract][Full Text] [Related]
16. Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance.
Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D
Pol J Pathol; 2006; 57(3):149-59. PubMed ID: 17219742
[TBL] [Abstract][Full Text] [Related]
17. Correlation of p53 with the clinicopathologic features and prognosis of colorectal adenocarcinoma.
Suzuki H; Matsumoto K; Koide A; Tada T; Fujino I; Okuda A; Shigemori C
Surg Today; 1994; 24(1):85-7. PubMed ID: 8054784
[TBL] [Abstract][Full Text] [Related]
18. Bio-pathological factors of prognostic value in colorectal adenocarcinomas.
Mottolese M; Buglioli S; Piperno G; Sperduti I; Giannarelli D; D'Angelo C; Cosimelli M
J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):163-6. PubMed ID: 16767924
[TBL] [Abstract][Full Text] [Related]
19. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.
Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI
Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743
[TBL] [Abstract][Full Text] [Related]
20. Influence of tumor localization on the prognostic value of P53 protein in colorectal adenocarcinomas.
Diez M; Medrano M; Mugüerza JM; Ramos P; Hernandez P; Villeta R; Martín A; Noguerales F; Ruiz A; Granell J
Anticancer Res; 2000; 20(5C):3907-12. PubMed ID: 11268475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
